METHOD FOR DETECTING AUTOPROCESSED, SECRETED PCSK9
    1.
    发明申请
    METHOD FOR DETECTING AUTOPROCESSED, SECRETED PCSK9 有权
    检测自动分析的PCSK9的方法

    公开(公告)号:US20100113575A1

    公开(公告)日:2010-05-06

    申请号:US12593342

    申请日:2008-03-21

    CPC分类号: C12Q1/37 C12N9/6424

    摘要: The present invention provides a method for detecting autoprocessed, secreted PCSK9, a protein involved in cholesterol homeostasis, and for effectively identifying compounds that inhibit autocleavage and secretion from cells. The disclosed method involves the insertion of an epitope tag into a PCSK9 expression construct immediately C-terminal to the pro domain ending at an amino acid residue corresponding to Q152 of human PCSK9. Upon autoprocessing, the epitope tag is exposed and capable of recognition by anti-epitope antibodies or other suitable identification system, allowing for the selective and exclusive identification and/or quantification of processed PCSK9. The present disclosure thus advances the goal of providing enabling technology to the art for the effective identification of therapeutics effective in combating coronary heart disease.

    摘要翻译: 本发明提供一种用于检测自身加工的分泌的PCSK9,参与胆固醇体内平衡的蛋白质以及有效地鉴定抑制细胞自噬和分泌的化合物的方法。 所公开的方法涉及将表位标签插入到终止于对应于人PCSK9的Q152的氨基酸残基的pro结构域的C末端的PCSK9表达构建体中。 在自动加工中,表位标签被暴露并且能够通过抗表位抗体或其他合适的识别系统识别,允许对加工的PCSK9的选择性和排他性鉴定和/或定量。 因此,本公开内容提供了为本领域提供有用的技术以有效鉴定有效对抗冠心病的治疗剂的目标。

    Method for detecting autoprocessed, secreted PCSK9
    2.
    发明授权
    Method for detecting autoprocessed, secreted PCSK9 有权
    检测自动加工,分泌的PCSK9的方法

    公开(公告)号:US08263353B2

    公开(公告)日:2012-09-11

    申请号:US12593342

    申请日:2008-03-21

    IPC分类号: G01N33/573 G01N33/567

    CPC分类号: C12Q1/37 C12N9/6424

    摘要: The present invention provides a method for detecting autoprocessed, secreted PCSK9, a protein involved in cholesterol homeostasis, and for effectively identifying compounds that inhibit autocleavage and secretion from cells. The disclosed method involves the insertion of an epitope tag into a PCSK9 expression construct immediately C-terminal to the pro domain ending at an amino acid residue corresponding to Q152 of human PCSK9. Upon autoprocessing, the epitope tag is exposed and capable of recognition by anti-epitope antibodies or other suitable identification system, allowing for the selective and exclusive identification and/or quantification of processed PCSK9. The present disclosure thus advances the goal of providing enabling technology to the art for the effective identification of therapeutics effective in combating coronary heart disease.

    摘要翻译: 本发明提供一种用于检测自身加工的分泌的PCSK9,参与胆固醇体内平衡的蛋白质以及有效地鉴定抑制细胞自噬和分泌的化合物的方法。 所公开的方法涉及将表位标签插入到终止于对应于人PCSK9的Q152的氨基酸残基的pro结构域的C末端的PCSK9表达构建体中。 在自动加工中,表位标签被暴露并且能够通过抗表位抗体或其他合适的识别系统识别,允许对加工的PCSK9的选择性和排他性鉴定和/或定量。 因此,本公开内容提供了为本领域提供有用的技术以有效鉴定有效对抗冠心病的治疗剂的目标。